Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting | New England Journal
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

New insights into the pathophysiology of chemotherapy-induced nausea and vomiting, a
better understanding of patients at risk, and the availability of new antiemetic agents have all …

Background Although all first-generation 5-HT 3 receptor antagonists demonstrate efficacy
in preventing acute chemotherapy-induced nausea and vomiting (CINV), effective …

THE GOAL OF ANTIEMETIC therapy is to prevent nausea and vomiting completely. This
goal is achieved for many patients receiving chemotherapy or radiation therapy, and is …

Purpose Olanzapine has been shown to be a safe and effective agent for the prevention of
chemotherapy-induced nausea and vomiting (CINV). Olanzapine may also be an effective …

In the mid-1980s it was discovered that serotonin (5-hydroxytryptamine; 5-HT) was at least
partially responsible for producing chemotherapy-induced nausea and vomiting. It was …

Nausea and vomiting are two of the most feared side effects of cancer chemotherapy and
radiotherapy. Chemotherapy-induced nausea and vomiting can be broadly categorized as …

Chemotherapy‐induced nausea and vomiting (CINV) is one of the most problematic adverse
events that affects the well‐being of cancer patients. Risk factors for CINV and its elimination …

Nausea is a complex sensation that results from the interaction of certain fixed biological
factors, such as gender, with changeable psychological factors, such as anxiety. This is the …

Abstract Since their introduction, 5-HT3 receptor antagonists have become the agents of
choice in the prevention of acute chemotherapy-induced nausea and vomiting and are …